Company Snapshot: CVM  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services

CEL-SCI CEO to Present at the Biotech / Pharma / Healthcare On-Line Forum
 
    VIENNA, Va., March 14 /PRNewswire-FirstCall/ -- CEL-SCI Corporation
(Amex: CVM) announces that its Chief Executive Officer, Geert Kersten, is a
featured presenter at the Biotech/Pharma/Healthcare On-line Forum. The
webcast presentation is scheduled for Thursday, March 15, 2007 at 10:30
a.m. (Eastern Daylight Time) and can be accessed via the Internet at
http://www.informedinvestors.com.
    The Company's lead product, Multikine(R), has FDA go-ahead to start a
global Phase III clinical trial in advanced primary head and neck cancer
patients. In a Phase II clinical trial, Multikine was shown to increase
overall survival by 33% 42 months after surgery.
    Company Contact:
    Gavin de Windt
    CEL-SCI Corporation
    (703) 506-9460
SOURCE CEL-SCI Corporation



Back to Topback to top

Related links:
  • http://www.cel-sci.com
  • http://www.informedinvestors.com
    CONTACT:
    Gavin de Windt, +1-703-506-9460, of CEL-SCI
    Corporation
    www.technorati.com Blogs Linking to this News Release at Technorati
    Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
    Terms and conditions, including restrictions on redistribution, apply.
    Copyright © 1996- PR Newswire Association LLC. All Rights Reserved.
    A United Business Media company.